High Court upholds ruling that NHS England can lawfully provide PrEP

GMFA’s interim CEO Ian Howley has commented on the ruling:

"GMFA welcomes the High Court’s decision to uphold the previous court ruling that the NHS is lawfully able to provide pre-exposure prophylaxis (PrEP).

It's been a disgrace that NHS England have been more concerned with paying for lawyers and dragging their heels over this, rather than getting on and commissioning PrEP for those who are most at risk.

Earlier this year San Francisco reported the number of newly diagnosed HIV infections in the city have continued to fall by 18%, the increased rate of this decline coincided with the approval of Truvada (tenofovir/emtricitabine) for PrEP.  A similar reduction in the UK could see a drop in new HIV transmissions by over 500 cases a year.

The current spend on HIV prevention is less than 2% of what we spend on treatment and care. This is not enough and it’s not working, we are still seeing thousands of new HIV infections every year in the UK. 

We now have all the tools required to effectively end new HIV infections, by investing and adding PrEP into our prevention armoury we will save costs in treatment later and help stop the spread of the virus. PrEP’s effectiveness has been proven. This is no time for hesitation or procrastination. PrEP is needed now."